| PCVX Shares Outstanding History Table | ||||||||||||||||||||||
Below is a table of the PCVX shares outstanding history going back to 6/12/2020:
Also see: PCVX Market Cap History PCVX YTD Return |
As of 5/4/2026 Vaxcyte has 144.40 million PCVX shares outstanding. Investors often track the PCVX shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows PCVX share count trends over time, with 10 historical shares outstanding datapoints presented, dating back to 6/12/2020.

| PCVX Shares Outstanding History Table | ||||||||||||||||||||||
Below is a table of the PCVX shares outstanding history going back to 6/12/2020:
Also see: PCVX Market Cap History PCVX YTD Return |
| PCVX Shares Outstanding History Chart | |||||||||||||||||||||||
PCVX Historical Shares Outstanding: +21.08% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||
| PCVX Stock Price Chart |
| About Vaxcyte Inc |
| Vaxcyte Inc. is a clinical-stage vaccine company. It is engaged in developing a spectrum conjugate and protein vaccines to prevent or treat bacterial infectious diseases. Its lead candidate, VAX-24, is a Phase III-ready 24-valent, carrier-sparing pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease (IPD). VAX-31, the Co.'s next generation 31-valent PCV is developed for the prevention of IPD in adults. Its pipeline also includes VAX-A1, VAX-PG, and VAX-GI. VAX-A1, a novel conjugate vaccine candidate designed to prevent disease caused by Group A Streptococcus (Group A Strep). We show 10 historical shares outstanding datapoints in our coverage of PCVX's shares outstanding history. Understanding the changing numbers of PCVX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like PCVX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching PCVX by allowing them to research PCVX shares outstanding history as well as any other stock in our coverage universe. |
| PCVX Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| PCVX Share Performance |
| Shares Outstanding Peers |
| Vaxcyte (PCVX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
PDCO Shares Outstanding History PDEX Shares Outstanding History PDSB Shares Outstanding History PEN Shares Outstanding History PEPG Shares Outstanding History PETV Shares Outstanding History PETX Shares Outstanding History PFE Shares Outstanding History PGEN Shares Outstanding History PGNX Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.